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Abstract for Oral Presentation/Paper 
Cytochrome P450 Monoxygenase Complex and Skin Development. 
Robert D. Finn*, Olivier Sparagano*, Lesley McLaughlin^, Colin Henderson^ & C. Roland Wolf^. 
*School of Life Sciences, Northumbria University & ^ Cancer Research UK Molecular Pharmacology 
Unit, University of Dundee. 
Cytochromes-P450 (CYPs), the first line-defence in the detoxification of drugs/harmful chemicals, 
play a role in various biological processes such as fatty acid metabolism. For these functions, CYPs 
form a complex with P450-oxidoreductase (POR) and cytochrome-b5 (cytb5). To investigate this 
complex in more detail, we developed mouse models where either POR or cytb5 was knocked out in 
the liver or the organism as a whole. Results show the absence of POR/cytb5 has a dramatic effect on 
all CYP functions 1, 2. In studies involving knockout cytb5 mice, a role in skin development was 
identified 3. Changes observed were very similar to patients suffering from ichthyosis skin disorders 
4. These disorders are associated with loss of  very long chain fatty acids. The CYP4 family function in 
the production of these fatty acids, therefore the defects observed in these mice maybe due to 
disrupted CYP4 activity. Supporting this hypothesis, genetics disruptions in CYP4F22, have been 
identified in patients suffering from lamellar ichthyosis 5. A role for this new CYP in very long chain 
fatty acid production in the skin remains unproven as does a link between its function and cytb5. This 
paper will report these findings and the directions which will be taken to decipher these links. 
 
1. Finn, R.D., et.al. (2009) Unsaturated fatty acid regulation of Cytochrome P450 expression via a 
CAR-dependent pathway. Biochemical Journal (417): 43-54. 
2. Finn, R.D., et.al. (2008) Defining the in vivo role for cytochrome b5 in Cytochrome P450 function 
through the conditional hepatic deletion of microsomal cytochrome b5. Journal of Biological 
Chemistry. 283(46): 31385-31393. 
3. Finn, R.D., et.al. (2010) Cytochrome b5 null mouse: a new model for studying inherited skin 
disorders and the role of unsaturated fatty acids in normal homeostasis. Transgenic Research. 
DOI: 10.1007/s11248-010-9426-1 
4. Akiyama M & Shimizu H (2008) An update on molecular aspects of the non-syndromic ichthyoses. 
Exp Dermatol 17(5): 373-382. 
5. Lefevre, C., et al. (2006) Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. 
Hum Mol Genet 15(5): 767-776. 
 
